Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
China flag China · Delayed Price · Currency is CNY
11.84
+0.12 (1.02%)
At close: Sep 14, 2026

SHE:301507 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
851.55778.67638.76580.36545.65487.91
Other Revenue
2.962.962.491.371.471.66
854.51781.63641.25581.73547.12489.58
Revenue Growth
20.98%21.89%10.23%6.33%11.75%11.41%
Cost of Revenue
413.01384.1288.19225.42219.47169.18
Gross Profit
441.5397.53353.06356.32327.65320.4
Selling, General & Admin
312.53280.54246.23240.88219.63226.67
Research & Development
21.9526.0823.9829.5627.1724.07
Other Operating Expenses
6.485.047.075.955.647.39
Operating Expenses
339.69310.4277.96277.3252.25258.51
Operating Income
101.8187.1475.179.0275.461.89
Interest Expense
-0.06-0.06-0.06-0.11-0.16-0.51
Interest & Investment Income
18.7122.129.513.988.7910.48
Currency Exchange Gain (Loss)
0.010.01-0.06---
Other Non Operating Income (Expenses)
-3.31-0.07-0.82-0.12-0.086.97
EBT Excluding Unusual Items
117.17109.12103.6692.7783.9578.84
Gain (Loss) on Sale of Investments
19.2823.88-0.51.06-0.46-2.65
Gain (Loss) on Sale of Assets
-0.22-0---00.18
Asset Writedown
0.82-0.08-0--0.27-0.29
Other Unusual Items
4.564.563.12.984.852.86
Pretax Income
141.61137.48106.2596.888.0778.94
Income Tax Expense
19.4916.4414.4211.169.068.71
Earnings From Continuing Operations
122.12121.0591.8385.6379.0170.22
Minority Interest in Earnings
-2.34-2.26----
Net Income
119.78118.7991.8385.6379.0170.22
Net Income to Common
119.78118.7991.8385.6379.0170.22
Net Income Growth
23.52%29.35%7.24%8.38%12.51%38.46%
Shares Outstanding (Basic)
362360353295263260
Shares Outstanding (Diluted)
362360353295263260
Shares Change
1.51%1.92%19.61%12.12%1.26%9.28%
EPS (Basic)
0.330.330.260.290.300.27
EPS (Diluted)
0.330.330.260.290.300.27
EPS Growth
21.69%26.92%-10.35%-3.33%11.11%26.70%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-8.66-19.1613.5772.0868.3718.75
Free Cash Flow Per Share
-0.02-0.050.040.240.260.07
Dividend Per Share
0.1500.1500.1000.100--
Dividend Growth
50.00%50.00%0%---
Gross Margin
51.67%50.86%55.06%61.25%59.89%65.44%
Operating Margin
11.92%11.15%11.71%13.58%13.78%12.64%
Profit Margin
14.02%15.20%14.32%14.72%14.44%14.34%
Free Cash Flow Margin
-1.01%-2.45%2.12%12.39%12.50%3.83%
EBITDA
129.59114.1197.47105.66106.7991.42
EBITDA Margin
15.17%14.60%15.20%18.16%19.52%18.67%
D&A For EBITDA
27.7826.9722.3726.6431.3929.53
EBIT
101.8187.1475.179.0275.461.89
EBIT Margin
11.92%11.15%11.71%13.58%13.78%12.64%
Effective Tax Rate
13.76%11.96%13.57%11.53%10.29%11.04%
Revenue as Reported
781.63781.63641.25581.73547.12-
Advertising Expenses
-41.7437.4134.4377.0591.52